This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain
NCT03993119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2021-09-29
Summary
This is an observational, multicenter and cross-sectional study in Non-valvular atrial fibrillation (NVAF) elderly patients currently on Non-vitamin K antagonist oral anticoagulant (NOAC) treatment for their stroke prevention.
Conditions
Interventions
- DRUG
-
Non-vitamin K antagonist oral anticoagulant
Non-vitamin K antagonist oral anticoagulant
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Mireia canals, (+34) 93 404 58 77 · [email protected]
Eligibility
- Min Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-30
- Primary Completion
- 2020-08-20
- Completion
- 2020-08-20
- FDA Drug
- Yes
Countries
- Spain
Study Locations
More Related Trials
-
Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
NCT05039359 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Two Different Regimens of the Antiarrhythmic Drug Amiodarone to Maintain Normal Sinus Rhythm After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation
NCT07273994 ·Status: RECRUITING ·Phase: PHASE4
-
Clinical Decision Support Tool for Improving the Adequacy of Anticoagulant Therapy in Non-valvular Atrial Fibrillation
NCT03367325 ·Status: UNKNOWN ·Phase: NA
-
Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation
NCT05469308 ·Status: UNKNOWN ·Phase: NA
-
Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
NCT00489736 ·Status: COMPLETED ·Phase: PHASE3
-
Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
NCT02618577 ·Status: TERMINATED ·Phase: PHASE3
-
the Role of Ivabradine in Causing AF in Patients With Chronic Coronary Syndrome
NCT05168189 ·Status: UNKNOWN
-
Laboratory Assessment of the Concentration of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
NCT04684056 ·Status: UNKNOWN
-
Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban)
NCT03455439 ·Status: COMPLETED
-
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
NCT01151137 ·Status: TERMINATED ·Phase: PHASE3
-
Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation
NCT01213368 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation
NCT00174785 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers
NCT01135017 ·Status: TERMINATED ·Phase: PHASE4
-
Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
NCT04594746 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Safety and Effectiveness on Oral Anticoagulants
NCT03765242 ·Status: COMPLETED
-
A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation
NCT05804747 ·Status: COMPLETED
-
Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure
NCT02446990 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
NCT02623049 ·Status: UNKNOWN
-
Concentrations of Amiodarone in Fat Tissue During Chronic Treatment
NCT00313443 ·Status: COMPLETED ·Phase: PHASE4
-
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
NCT00526136 ·Status: COMPLETED ·Phase: PHASE2
-
Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
NCT05130268 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement
NCT01198873 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
NCT05350969 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-diltiazem, Calcium Versus Placebo for Atrial Fibrillation With Rapid Ventricular Response
NCT05691959 ·Status: UNKNOWN ·Phase: PHASE2
-
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
NCT04747496 ·Status: COMPLETED